EP Lab Digest

May 1, 2020 | EP Lab Digest
Rapid Transition of a Traditional Cardiology/Electrophysiology Clinic to Telehealth in the Setting of an Emergent Pandemic

The world is facing an unprecedented modern pandemic that has posed many new challenges to healthcare providers.

May 1, 2020 | EP Lab Digest
Ablation of Ventricular Tachycardia Using an Epicardial-Only Scar Modification Approach Guided by Cardiac Imaging

Percutaneous catheter ablation with a strategy of scar modification is a validated technique for management of ventricular tachycardia (VT) and is particularly advantageous in the setting of multiple hemodynamically unstable circuits.

Apr 27, 2020 | EP Lab Digest
The LAAO Program at The University of Kansas Health System: Current Strategies, Protocols, Quality Metrics, and Research

The cardiac electrophysiology (EP) program at The University of Kansas Health System (KU) in Kansas City is one of the largest electrophysiology programs in the Midwest offering comprehensive services in all domains in electrophysiology.

Apr 6, 2020 | EP Lab Digest
Building a Safe and Successful Extraction Program: Experience at Houston Methodist The Woodlands Hospital

In this interview, we speak with Rajesh Venkataraman, MD, FHRS from Houston Methodist the Woodlands Hospital in The Woodlands, Texas.

Mar 2, 2020 | EP Lab Digest
Improving Workflow and Addressing Challenges in the Device Clinic

Chris* knew something was not working right with his heart, but this felt different from his previous heart attack five years ago.

Feb 3, 2020 | EP Lab Digest
Amplatzer Amulet LAA Occluder Will be Compared to Anticoagulants in CATALYST Trial

The U.S. Food and Drug Administration (FDA) has approved a the CATALYST trial designed to assess Abbott’s Amplatzer Amulet left atrial appendage (LAA) occluder for people with atrial fibrillation (AF or AFib).

Feb 2, 2020 | EP Lab Digest
Intraoperative Epicardial Voltage Mapping to Guide Hybrid Convergent Ablation of Persistent Atrial Fibrillation

Atrial fibrillation (AF) ablation has evolved over the past 30 years into an effective treatment option for patients with AF.

Jan 2, 2020 | EP Lab Digest
Catheter Ablation for Atrial Fibrillation Without X-Rays: The Zero Fluoro Technique

Catheter ablation is currently the most effective treatment for atrial fibrillation (AF).1,2 It is widely performed in various centers around the world given the increasing prevalence of AF in the population and the modest response to antiarrhythmic medications.

Jan 2, 2020 | EP Lab Digest
Three-Dimensional Printing in Cardiac Electrophysiology: Current Applications and Future Directions

With the advancements in therapeutic options offered in today’s cardiac electrophysiology (EP) practice, as well as the increased complexity of patients with congenital and acquired heart disease requiring invasive procedures to treat heart rhythm disorders, there is an increased need for cardiac electrophysiologists to better understand the complexity of their patients’ unique cardiac anatomy.

Nov 25, 2019 | EP Lab Digest
Thrombosis Research Institute Launches Innovative Risk Calculator for Predicting Stroke, Major Bleeding and Mortality in Atrial Fibrillation Over Two Years

Thrombosis Research Institute (TRI) has launched the GARFIELD-AF Risk Calculator, an innovative tool for aiding clinician decision making in treating patients with newly diagnosed atrial fibrillation (AF).